Premium
BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN HODGKIN'S LYMPHOMAS: A RETROSPECTIVE EXPERIENCE BY THE RETE EMATOLOGICA PUGLIESE (REP)
Author(s) -
Gaudio F.,
Mazza P.,
Mele A.,
Palazzo G.,
Carella A.,
Pastore D.,
Cascavilla N.,
Pavone V.,
Specchia G.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.172_2631
Subject(s) - medicine , incidence (geometry) , cumulative incidence , retrospective cohort study , brentuximab vedotin , graft versus host disease , transplantation , oncology , surgery , lymphoma , hodgkin lymphoma , physics , optics